Literature DB >> 33654193

Annotation and cluster analysis of long noncoding RNA linked to male sex and estrogen in cancers.

Shouping Liu1,2, Weiwei Lai1,2, Ying Shi1,2, Na Liu1,2, Lianlian Ouyang1,2, Ziying Zhang1,2, Ling Chen1,2, Xiang Wang3, Banglun Qian3, Desheng Xiao1,4,5, Qin Yan6, Ya Cao1, Shuang Liu7,8, Yongguang Tao9,10,11.   

Abstract

The sex difference in cancer occurrence is a consistent finding in cancer epidemiology. Several solid tumors, including lung cancer, colorectal cancer, hepatic carcinoma, and renal carcinoma, are generally more common in males. Although sexual dimorphism is attributed to hormonal or behavioral differences, evidence for the function of lncRNA is lacking in sex-specific cancers. We show here that LINC00263 is one of the most dysregulated lncRNAs in lung adenocarcinomas and is upregulated in lung adenocarcinoma, colorectal cancer, and renal carcinoma, especially in male patients compared to females. LINC00263 functions as an oncogene by promoting translocation of p65 into the nucleus to activate the NF-κB-signaling pathway through interaction with IKKα in the cytoplasm. The expression of LINC00263 is strongly correlated with ESR1, and it is decreased after treatment with estrogen. Ligand-activated ER could inhibit the function of LINC00263 by inhibiting NF-κB from cytoplasmic translocation into the nucleus. The inhibitory effect of estrogen on LINC00263 indicates its differential expression in male and female patients. Our findings indicate that LINC00263 is linked to male sex and estrogen as an oncogene, and these findings might help in the exploration of the mechanisms of differential gene regulation in sex-specific cancers.

Year:  2020        PMID: 33654193     DOI: 10.1038/s41698-020-0110-5

Source DB:  PubMed          Journal:  NPJ Precis Oncol        ISSN: 2397-768X


  56 in total

Review 1.  Sexual dimorphism in environmental epigenetic programming.

Authors:  Anne Gabory; Linda Attig; Claudine Junien
Journal:  Mol Cell Endocrinol       Date:  2009-03-09       Impact factor: 4.102

2.  Effect of luteinizing hormone-induced prohibitin and matrix metalloproteinases on ovarian epithelial tumor cell proliferation.

Authors:  Yue Wang; Hong Liao; Holly C Zheng; Linmin Li; Lin Jia; Zhengbo Zhang; Wenxin Zheng
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

3.  Cancer statistics, 2015.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-01-05       Impact factor: 508.702

Review 4.  Gonadotropin signalling in epithelial ovarian cancer.

Authors:  Inga Mertens-Walker; Robert C Baxter; Deborah J Marsh
Journal:  Cancer Lett       Date:  2012-05-22       Impact factor: 8.679

Review 5.  Prolactin in breast and prostate cancer: molecular and genetic perspectives.

Authors:  Eric M Jacobson; Eric R Hugo; Dana C Borcherding; Nira Ben-Jonathan
Journal:  Discov Med       Date:  2011-04       Impact factor: 2.970

Review 6.  The androgen receptor in health and disease.

Authors:  Takahiro Matsumoto; Matomo Sakari; Maiko Okada; Atsushi Yokoyama; Sayuri Takahashi; Alexander Kouzmenko; Shigeaki Kato
Journal:  Annu Rev Physiol       Date:  2012-11-13       Impact factor: 19.318

Review 7.  Management of non-small-cell lung cancer: recent developments.

Authors:  Martin Reck; David F Heigener; Tony Mok; Jean-Charles Soria; Klaus F Rabe
Journal:  Lancet       Date:  2013-08-24       Impact factor: 79.321

Review 8.  Sex-specific genetic architecture of human disease.

Authors:  Carole Ober; Dagan A Loisel; Yoav Gilad
Journal:  Nat Rev Genet       Date:  2008-12       Impact factor: 53.242

9.  Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in mice.

Authors:  Kristina M Mueller; Jan-Wilhelm Kornfeld; Katrin Friedbichler; Leander Blaas; Gerda Egger; Harald Esterbauer; Peter Hasselblatt; Michaela Schlederer; Susanne Haindl; Kay-Uwe Wagner; David Engblom; Guenter Haemmerle; Dagmar Kratky; Veronika Sexl; Lukas Kenner; Andrey V Kozlov; Luigi Terracciano; Rudolf Zechner; Guenther Schuetz; Emilio Casanova; J Andrew Pospisilik; Markus H Heim; Richard Moriggl
Journal:  Hepatology       Date:  2011-10       Impact factor: 17.425

10.  Gender differences in cancer susceptibility: an inadequately addressed issue.

Authors:  M Tevfik Dorak; Ebru Karpuzoglu
Journal:  Front Genet       Date:  2012-11-28       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.